About this trial
assess the efficacy of metoclopramide in reducing the gastric contents and volume in pediatric trauma prepared for urgent surgical interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Paediatric urgent trauma
Disqualifiers
Guardian' refusal.
Presence of head trauma.
Trial design
Parallel
Treatments tested in this trial
Metoclopramide (Maxolon)
DrugParticipants will receive 0.15 mg/kg of metoclopramide administered intravenously. The drug will be diluted in 2 ml of solution prior to administration.
Saline
Drugpatients will recive normal saline 0.9% 2ml intravenous
Treatment groups
Trial outcomes
Primary outcomes
ultrasonographic assessment of the effect of metoclopramide on morphology of the gastric antrum
Ultrasonographic evaluation was performed to study the impact of metoclopramide on the morphology of the gastric antrum. The cross-sectional area (CSA) of the antrum was calculated using the Bolondi et al. method with the formula:Antral CSA = π (AP × CC) / 4
Secondary outcomes
effect of metoclopramide on gastric grading was assessed using a three-point grading systems
The effect of metoclopramide on gastric grading was evaluated using a three-point grading system as follows: G-0: The antrum is flat and empty in both supine and right lateral positions (RLP). G-1: The antrum contains fluid in the right lateral position but is empty in the supine position. G-2: The antrum contains fluid in both supine and right lateral positions.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: